Oramed grants Yehuda Reznick 72,780 Board shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ORAMED PHARMACEUTICALS INC. director Yehuda Reznick received two restricted stock awards on November 12, 2026: 72,780 shares for annual Board awards covering fiscal years 2027 and 2028, and 2,890 shares for fiscal year 2027 committee awards. The Board award vests in 12 substantially equal quarterly installments beginning April 1, 2027 and April 1, 2028, respectively; the committee award vests in four substantially equal quarterly installments beginning April 1, 2027. Both awards are subject to continued service. The issuer stated that no annual Board award will be granted to Reznick for fiscal year 2028.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 72,780 | -- | -- |
| Grant/Award | Common Stock F2 | 2,890 | -- | -- |
Footnotes (2)
- F1. On November 12, 2026, the issuer granted to the reporting person a restricted stock award of 72,780 shares under the issuer's Amended and Restated 2019 Stock Incentive Plan, representing the reporting person's annual Board awards for fiscal years 2027 and 2028. Of these shares, 36,390 vest in twelve substantially equal quarterly installments beginning April 1, 2027, and 36,390 vest in twelve substantially equal quarterly installments beginning April 1, 2028, in each case subject to the reporting person's continued service. No annual Board award will be granted to the reporting person for fiscal year 2028.
- F2. On November 12, 2026, the issuer granted to the reporting person a restricted stock award of 2,890 shares under the issuer's Amended and Restated 2019 Stock Incentive Plan, representing the reporting person's fiscal year 2027 committee awards, which vest in four substantially equal quarterly installments beginning April 1, 2027, subject to the reporting person's continued service.
Key Figures
Key Terms
restricted stock award financial
substantially equal quarterly installments financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How do Yehuda Reznick's ORMP stock awards vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.